Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 4621 AL 4635

A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer's Disease

Dubé S, Megerian JT, Malamut R.

J Prev Alzheimers Dis. 2018;5(2):120-133. doi: 10.14283/jpad.2018.17.

Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease

Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L.

J Prev Alzheimers Dis. 2018;5(2):149-154. doi: 10.14283/jpad.2018.18.

New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease

Zhong KL, Chen F, Hong H, Ke X, Lv YG, Tang SS, Zhu YB.

Metab Brain Dis. 2018 Aug;33(4):1009-1018. doi: 10.1007/s11011-018-0227-1. Epub 2018 Apr 6.

Exercise Intervention Associated with Cognitive Improvement in Alzheimer's Disease

Cui MY, Lin Y, Sheng JY, Zhang X, Cui RJ.

Neural Plast. 2018 Mar 11;2018:9234105. doi: 10.1155/2018/9234105. eCollection 2018.

The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

Creese B, Da Silva MV, Johar I, Ballard C.

Expert Rev Neurother. 2018 Jun;18(6):461-467. doi: 10.1080/14737175.2018.1476140. Epub 2018 May 21.

Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis

Liang JH, Xu Y, Lin L, Jia RX, Zhang HB, Hang L.

Medicine (Baltimore). 2018 May;97(20):e10744. doi: 10.1097/MD.0000000000010744.

Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease

Hussain A, Tabrez ES, Mavrych V, Bolgova O, Peela JR.

Crit Rev Eukaryot Gene Expr. 2018;28(1):67-72. doi: 10.1615/CritRevEukaryotGeneExpr.2018021391.

Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis

Cao B, Rosenblat JD, Brietzke E, Park C, Lee Y, Musial N, Pan Z, Mansur RB, McIntyre RS.

Diabetes Obes Metab. 2018 Oct;20(10):2467-2471. doi: 10.1111/dom.13373. Epub 2018 Jun 19.

Oxidative Stress in Elderly with Different Cognitive Status: My Mind Project

Fattoretti P, Malavolta M, Fabbietti P, Papa R, Giacconi R, Costarelli L, Galeazzi R, Paoloni C, Postacchini D, Lattanzio F, Giuli C.

J Alzheimers Dis. 2018;63(4):1405-1414. doi: 10.3233/JAD-171117.

Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design

Devanand DP, Strickler JG, Huey ED, Crocco E, Forester BP, Husain MM, Vahia IV, Andrews H, Wall MM, Pelton GH.

Contemp Clin Trials. 2018 Aug;71:33-39. doi: 10.1016/j.cct.2018.05.019. Epub 2018 May 31.

Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease

Devanand DP.

Curr Neurol Neurosci Rep. 2018 Jul 14;18(9):55. doi: 10.1007/s11910-018-0863-1.

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus

Kales HC, Lyketsos CG, Miller EM, Ballard C.

Int Psychogeriatr. 2019 Jan;31(1):83-90. doi: 10.1017/S1041610218000534. Epub 2018 Aug 2.

Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis

Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C.

BMC Geriatr. 2018 Aug 7;18(1):175. doi: 10.1186/s12877-018-0864-6.

Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial

Henskens M, Nauta IM, van Eekeren MCA, Scherder EJA.

Dement Geriatr Cogn Disord. 2018;46(1-2):60-80. doi: 10.1159/000491818. Epub 2018 Aug 24.

Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis

Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H.

Neurosci Lett. 2018 Nov 1;686:10-16. doi: 10.1016/j.neulet.2018.08.038. Epub 2018 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias